eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2023
vol. 48
 
Share:
Share:
abstract:
Experimental immunology

Notch signaling pathway-based classification of bladder cancer in relation to tumor immune infiltration

Yang Bin
1
,
Li Guikang
1
,
Huang Jin
2
,
Zhang Xue
3
,
Wang Ruihan
4
,
Zhang Jianchao
5

  1. Department of Urology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
  2. Department of Urology, Shanghai Pudong New Area Gongli Hospital, Shanghai, China
  3. Department of Operating Room, Tianqiao People’s Hospital of Jinan, Jinan, Shandong, China
  4. Class 11, Clinical Specialty, Weifang Medical College,
  5. Department of Urology, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, China
Cent Eur J Immunol 2023; 48 (4): 274-289
Online publish date: 2024/02/19
View full text Get citation
 
PlumX metrics:
Introduction:
The role of the Notch signaling pathway in the development of various tumors has received increasing attention, but the relationship between the Notch signaling pathway and the prognosis of bladder cancer has rarely been studied. The aim of this study was to investigate the function and risk evaluation value of Notch signaling pathway-related genes (NRGs) in bladder cancer.

Material and methods:
The list of genes related to the Notch signaling pathway was obtained from the molecular signature database. The bladder cancer dataset was obtained from The Cancer Genome Atlas (TCGA) database. Cox regression analysis and Lasso regression analysis were used to construct the characteristics for predicting the overall survival of patients with bladder cancer. The CIBERSORT algorithm was used to evaluate the infiltration of peripheral immune cells in different risk subgroups.

Results:
NRG expression was remarkably dysregulated in bladder cancer. Next, bladder cancer was classified into two subtypes (C1 and C2) based on NRG expression levels. The two subtypes had a significant difference in prognosis and were closely related to clinical characteristics. Further analysis showed that immune cell infiltration and immune scores were also significantly different between the two subtypes.

Conclusions:
Notch signaling pathway-based bladder cancer typing has different prognoses and may be related to tumor immunity. NRGs can be identified for risk evaluation and help improve clinical decision-making.

keywords:

Notch pathway, bladder cancer, immune infiltration, prognosis, bioinformatic analysis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.